Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155461 | SCV000205152 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Thr439Thr in exon 13 of AP3B1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.5% (47/8600) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs75248449). |
Illumina Laboratory Services, |
RCV000349780 | SCV000458304 | uncertain significance | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000551368 | SCV000639568 | benign | Hermansky-Pudlak syndrome 2 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000155461 | SCV002069765 | likely benign | not specified | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002260996 | SCV002542756 | likely benign | Autoinflammatory syndrome | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573689 | SCV004032606 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | AP3B1: BP4, BP7 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573689 | SCV001799929 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000155461 | SCV001918646 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573689 | SCV001969421 | likely benign | not provided | no assertion criteria provided | clinical testing |